Autres langues

11/09/25 Bausch Health Companies Inc. completed the acquisition of DURECT Corporation.
11/09/25 Bausch Health Completes US$63 Million Durect Acquisition, Adds Breakthrough Hepatitis Therapy to Pipeline
11/09/25 Durect Corporation Announces Board Changes
11/09/25 Bausch Health completes acquisition of Durect Corporation, expanding late-stage liver disease portfolio
11/09/25 Bausch Health Completes $63 Million Acquisition of Durect
11/09/25 DURECT Corporation(NasdaqCM:DRRX) dropped from S&P TMI Index
11/09/25 DURECT Corporation(NasdaqCM:DRRX) dropped from NASDAQ Composite Index
27/08/25 Bausch Health Announces Extension of DURECT Corporation Tender Offer to September 10, 2025
26/08/25 Bausch Health Extends Tender Offer for DURECT Shares to Sept. 10
22/08/25 Durect Insider Bought Shares Worth $386,666, According to a Recent SEC Filing
12/08/25 Durect: Q2 Earnings Snapshot
12/08/25 DURECT Corporation Reports Second Quarter 2025 Financial Results and Provides Update on Proposed Acquisition by Bausch Health
12/08/25 DURECT Corporation Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2025
09/08/25 Durect Bausch Health extend tender offer date to Aug 12 - SEC filing
29/07/25 Bausch Health Companies Inc. entered into an Agreement and Plan of Merger to acquire DURECT Corporation for approximately $400 million.
29/07/25 Bausch Health to Acquire Durect for $63 Million
29/07/25 Bausch Health to Acquire Nasdaq-listed Durect for US$63 Million
15/05/25 Durect: Q1 Earnings Snapshot
13/05/25 DURECT Corporation Reports First Quarter 2025 Financial Results And Provides Business Update
13/05/25 DURECT Corporation Reports First Quarter 2025 Financial Results and Provides Business Update
13/05/25 DURECT Corporation Reports Earnings Results for the First Quarter Ended March 31, 2025
27/03/25 DURECT Corporation Auditor Raises 'Going Concern' Doubt
26/03/25 Durect: Q4 Earnings Snapshot
26/03/25 DURECT Corporation Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2024
19/03/25 DURECT Corporation to Announce Fourth Quarter and Full Year 2024 Financial Results and Provide a Business Update
Aucun résultat pour cette recherche